Abstract:Objective: The objective of this study was to compare the outcomes of pharmacomechanical thrombolysis and thrombectomy (PCDT) plus catheter-directed thrombolysis (CDT) vs CDT alone for the treatment of acute iliofemoral deep vein thrombosis (DVT) and summarize the clinical experience, safety outcomes, and short- and long-term efficacy.Methods: We performed a 4-year retrospective, case-control study. A total of 95 consecutive patients with acute symptomatic iliofemoral deep vein thrombosis (DVT) with a symptom duration of <= 7 days involving the iliac and/or common femoral veins underwent endovascular interventions. The patients were divided into two groups according to their clinical indications: PCDT plus CDT vs CDT alone. Statistical analyses were used to compare the clinical characteristics and outcomes between the two groups. Additionally, the patients were followed up for 3 to 36 months after treatment, and the proportions of post-thrombotic syndrome (PTS) and moderate to severe PTS were analyzed using the Kaplan-Meier survival method.Results: A total of 95 consecutive patients were analyzed in this retrospective study, of whom, 51 underwent CDT alone and 44 underwent PCDT plus CDT. Between the two groups, in terms of immediate-term efficacy and safety, significant differences were found in the catheter retention time (60.64 +/- 12.04 hours vs 19.42 +/- 4.04 hours; P < .001), dosages of urokinase required (5.82 +/- 0.81 million units vs 1.80 +/- 0.64 million units; P < .001), the detumescence rate at 24 hours postoperatively (48.46% +/- 8.62% vs 76.79% +/- 7.98%; P = .026), the descent velocity of D-dimer per day (2266.28 +/- 1358.26 mu g/L/D vs 3842.34 +/- 2048.02 mu g/L/D; P = .018), total hospitalization stay (6.2 +/- 1.40 days vs 3.8 +/- 0.70 days; P = .024), number of postoperative angiograms (2.4 +/- 0.80 vs 1.2 +/- 0.30; P = .042), and grade III venous patency (>95% lysis: 54.5% vs 68.6%; P = .047). Furthermore, during the follow-up period, significant differences were found in the incidence of PTS (Villalta scale >= 5 or a venous ulcer: 47.0% vs 27.7%; P = .037), and the incidence proportion of moderate to severe PTS at 12 months (15.7% vs 4.5%; P = .024) and 24 months (35.3% vs 11.4%; P = .016).Conclusions: Compared with CDT alone, in the iliofemoral DVT subgroup with a symptom duration of <= 7 days, PCDT plus CDT could significantly relieve early leg symptoms, shorten the hospitalization stay, reduce bleeding complications, promote long-term venous patency, and decrease the occurrence of PTS and the incidence proportion of moderate to severe PTS. Thus, the short- and long-term outcomes both support the superiority of PCDT plus CDT vs CDT in this subgroup.

Comparative Study of Early Therapeutic Effects of Catheter-directed Thrombolysis and Pharmaco Mechanical Thrombolysis for Lower Extremity Deep Vein Thrombosis

Application evaluation of different approaches for catheter-directed thrombolysis in acute lower-extremity deep venous thrombosis

Clinical experience of thrombectomy and catheter-directed thrombolysis in the treatment of lower extremity deep vein thrombosis

Catheter Directed Thrombolysis for Treatment of Acute Deep Venous Thrombosis of the Lower Extremity of the Effect and Safety Analysis in 116 Cases

Outcome Comparisons of Anticoagulation, Systematic Thrombolysis and Catheter-Directed Thrombolysis in the Treatment of Lower Extremity Acute Deep Venous Thrombosis

Catheter-directed Thrombolysis Compared with Anticoagulation Treatment for Acute Deep Venous Thrombosis-Short and Mid-Term Result

Early and Midterm Outcomes of Acute Lower Extremity Deep Venous Thrombosis Treated by Catheter Directed Thrombolysis

A systematic review and meta-analysis of the relative safety and efficacy of treating lower extremity deep vein thrombosis via pharmacomechanical thrombectomy and catheter-directed thrombolysis

Analysis Thrombolysis with Anticoagulation Treatment for Early Stage of Deep Vein Thrombosis in the Lower Extremities

Comparison of clear effect and the complications, and short and mid-term effects between ultrasound-guided and non-guided catheter-directed thrombolysis in the treatment of deep venous thrombosis of lower extremity

Comparison of Low-Molecular-weight-heparin and Unfractionated Heparin for Acute PTE

Comparative Outcomes of Catheter-Directed Thrombolysis Versus AngioJet Pharmacomechanical Catheter-Directed Thrombolysis for Treatment of Acute Iliofemoral Deep Vein Thrombosis.

Comparison of Surgical Thrombectomy and Catheter-Directed Thrombolysis for Acute Deep Vein Thrombosis of the Low Extremity Caused by Cockett Syndrome

Ultrasound-guided versus non-guided catheter-directed thrombolysis in the treatment of deep venous thrombosis

Analysis of Efficacy of Therapy in 165 Cases of Deep Vein Thrombosis of Lower Extremity

Efficacy of percutaneous mechanical thrombus removal in acute lower extremity deep venous thrombosis

Clinical efficacy of one-stage thrombus removal via contralateral femoral and ipsilateral tibial venous access for pharmacomechanical thrombectomy in entire-limb acute deep vein thrombosis

Catheter-directed Thrombolysis for Acute Lower Limb Deep Venous Thrombosis

Comparative Outcomes of Catheter-Directed Thrombolysis versus AngioJet Pharmaco-mechanical Catheter-Directed Thrombolysis for Treatment of Acute Iliofemoral Deep Vein Thrombosis

The Relationship between Efficacy of Thrombectomy and the Course of Deep Vein Thrombosis of the Lower Extremity

Intra-arterial Contimuous Thrombolytic Therapy for Lower Extremity Deep Vein Thrombosis